Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000349170

Medchemexpress LLC N,N'-Dinitrosopiperazine | 140-79-4 | 99.94% | 144.13 | 1 ML
SDP

Catalog No. 5000349170
Encompass_Preferred

N,N'-Dinitrosopiperazine (DNP) is identified as a carcinogen with specificity for nasopharyngeal epithelium. It facilitates nasopharyngeal carcinoma (NPC) metastasis by regulating various signaling pathways, notably through the phosphorylation of LYRIC at serine 568. This compound is offered as a high-purity solution for research applications.

  • Carcinogen with specificity for nasopharyngeal epithelium
  • Facilitates NPC metastasis
  • Regulates multiple signaling pathways via protein phosphorylation
  • Targets LYRIC at serine 568
  • Supplied as a 10 mM solution in DMSO
  • High purity of 99.94%

Catalog No. 50-003-49170 Supplier Medchemexpress LLC Supplier No. HY13643310MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

N,N'-Dinitrosopiperazine (DNP) is identified as a carcinogen with specificity for nasopharyngeal epithelium. It facilitates nasopharyngeal carcinoma (NPC) metastasis by regulating various signaling pathways, notably through the phosphorylation of LYRIC at serine 568. This compound is offered as a high-purity solution for research applications.

  • Carcinogen with specificity for nasopharyngeal epithelium
  • Facilitates NPC metastasis
  • Regulates multiple signaling pathways via protein phosphorylation
  • Targets LYRIC at serine 568
  • Supplied as a 10 mM solution in DMSO
  • High purity of 99.94%

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.